Study of CX-4945 in Patients With Relapsed or Refractory Multiple Myeloma
NCT01199718
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
22
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Myeloma
Interventions
DRUG:
CX-4945
Sponsor
Cylene Pharmaceuticals